Product Information
NEOMYC-POLYM-DEXAMET EYE OINTM is a generic product labeled by Bausch & Lomb Incorporated, priced at $2.7506 per GM under NDC 24208079535. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
1; 3.5; 10000 mg/g; mg/g; [USP'U]/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208079535
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA064063On Market Since
7/25/1994
Pharmacological Classes
Price Statistics
The NADAC for NEOMYC-POLYM-DEXAMET EYE OINTM has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 37.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7506 per GM |
|---|---|
| All-time high | $4.8575 (Oct 15, 2014) |
| All-time low | $2.1009 (Nov 20, 2024) |
| 52-week high | $2.9358 |
| 52-week low | $2.6623 |
| Median price | $3.2812 |
| Average price | $3.4507 |
| Largest weekly change | +38.7% (Oct 23, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Neomycin Sulfate, Polymyxin B Sulfate, and Dexamethasone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NEOMYC-POLYM-DEXAMET EYE OINTM?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-POLYM-DEXAMET EYE OINTM, manufactured by Bausch & Lomb Incorporated, is $2.7506 per GM (NDC 24208079535), effective Jun 24, 2026.
How has the price of NEOMYC-POLYM-DEXAMET EYE OINTM changed over time?
Over the history we have for it, the NADAC for NEOMYC-POLYM-DEXAMET EYE OINTM has declined 37.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYC-POLYM-DEXAMET EYE OINTM?
Since Nov 28, 2013, the NADAC for NEOMYC-POLYM-DEXAMET EYE OINTM has ranged from a low of $2.1009 (Nov 20, 2024) to a high of $4.8575 (Oct 15, 2014), with a median of $3.2812 per GM.
Are there cheaper alternatives to NEOMYC-POLYM-DEXAMET EYE OINTM?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NEOMYC-POLYM-DEXAMET EYE OINTM, so no direct lower-cost alternative is listed.
Who manufactures NEOMYC-POLYM-DEXAMET EYE OINTM?
NEOMYC-POLYM-DEXAMET EYE OINTM (NDC 24208079535) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.
Related Drugs
Same classification